AFT Pharmaceuticals says first-half loss widened to $8.4M, cash burn continues

AFT Pharmaceuticals says first-half loss widened to $8.4M, cash burn continues
Jonathan Underhill
By Jonathan Underhill Nov. 11 (BusinessDesk) - AFT Pharmaceuticals, the maker of ibuprofen-paracetamol painkiller Maxigesic, said its operating loss widened in the first half as it continues with its global rollout and trials new versions of its products. The operating loss was about $8.4 million in the six months ended Sept. 30, from a loss of $3.5 million a year earlier, the Auckland-based company said in a statement. Revenue rose 1 percent to $29.8 million. At the company's annual meeting in August, it said it was on track to break...